{{Rsnum
|rsid=37370
|Chromosome=5
|Orientation=plus
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene=AGXT2
|position=35039381
|Gene_s=AGXT2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 0.0 | 17.7 | 82.3
| HCB | 18.4 | 49.3 | 32.4
| JPT | 20.5 | 50.0 | 29.5
| YRI | 0.0 | 0.0 | 0.0
| ASW | 0.0 | 5.3 | 94.7
| CHB | 18.4 | 49.3 | 32.4
| CHD | 24.8 | 45.0 | 30.3
| GIH | 3.0 | 34.0 | 63.0
| LWK | 0.0 | 0.9 | 99.1
| MEX | 13.8 | 37.9 | 48.3
| MKK | 0.0 | 7.7 | 92.3
| TSI | 1.0 | 20.6 | 78.4
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=24159190
  |Trait=Serum dimethylarginine levels (asymmetric)
  |Title=Genome-wide association study on dimethylarginines reveals novel AGXT2 variants associated with heart rate variability but not with overall mortality.
  |RiskAllele=T
  |Pval=1E-7
  |OR=.18
  |ORtxt=[0.12-0.25] unit increase
  }}

{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}